Neogen Beats Q3 Earnings & Revenue, Boosts Full-Year Outlook
NEOG has more than doubled off its 52-week low of $3.87.
Summary
Neogen Corporation reported fiscal third-quarter results that exceeded analyst expectations, with adjusted earnings of 9 cents per share against an anticipated 6 cents, and revenue of $211.2 million surpassing the $204.5 million consensus. Despite a 4.4% decline in overall revenue year-over-year and an increased net loss, the company raised its full-year revenue guidance to $857 million-$860 million, up from $845 million-$855 million. This positive outlook is driven by strong performance in its Food Safety segment, which saw a 2.6% revenue increase. However, the Animal Safety business faced a significant 20% revenue drop due to third-party supplier challenges, which management is actively addressing. This mixed but ultimately positive earnings report, particularly the raised guidance, is a material development for investors.
At the time of this announcement, NEOG was trading at $9.47 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $3.87 to $11.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.